magnesium sulfate Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4290 7487-88-9

Description:

MoleculeDescription

Synonyms:

  • magnesium sulfate
  • sulfuric acid magnesium salt
  • epsom salt
  • magnesium sulphate
  • magnesium sulfate heptahydrate
  • magnesium sulfate, unspecified
  • magnesium sulfate anhydrous
A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
  • Molecular weight: 120.36
  • Formula: MgO4S
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
7 g O
3 g O
1 g P

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Oct. 6, 1981 FDA BAXTER HLTHCARE

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Exposure during pregnancy 287.03 12.78 279 18289 107933 46559561
Premature baby 208.34 12.78 114 18454 17998 46649496
Premature delivery 167.11 12.78 106 18462 21963 46645531
Hypermagnesaemia 167.06 12.78 44 18524 878 46666616
Maternal exposure during pregnancy 164.29 12.78 203 18365 102346 46565148
Pulmonary oedema 131.89 12.78 130 18438 50975 46616519
Foetal exposure during pregnancy 128.94 12.78 103 18465 30644 46636850
PCO2 increased 127.20 12.78 38 18530 1216 46666278
Blood pH decreased 114.23 12.78 42 18526 2585 46664909
Blood bicarbonate decreased 99.70 12.78 39 18529 2846 46664648
Low birth weight baby 84.82 12.78 42 18526 5392 46662102
Renal ischaemia 82.21 12.78 23 18545 580 46666914
Diabetes insipidus 80.85 12.78 31 18537 2143 46665351
Propofol infusion syndrome 80.66 12.78 24 18544 757 46666737
Pre-eclampsia 80.14 12.78 46 18522 7948 46659546
Cytokine release syndrome 73.82 12.78 40 18528 6183 46661311
Foetal death 73.74 12.78 45 18523 8698 46658796
Hypomagnesaemia 73.65 12.78 65 18503 22145 46645349
Mitochondrial DNULL mutation 65.34 12.78 16 18552 235 46667259
PO2 increased 65.11 12.78 21 18547 869 46666625
Caesarean section 59.91 12.78 51 18517 16552 46650942
Blood magnesium decreased 59.71 12.78 43 18525 10949 46656545
Rheumatoid arthritis 54.83 12.78 14 18554 240201 46427293
Blood lactic acid increased 52.59 12.78 31 18537 5626 46661868
Oxygen saturation abnormal 51.50 12.78 24 18544 2694 46664800
Arthralgia 51.25 12.78 42 18526 364561 46302933
Premature labour 49.80 12.78 39 18529 11260 46656234
Gene mutation 49.68 12.78 18 18550 1062 46666432
Hypocalcaemia 47.64 12.78 56 18512 26729 46640765
Encephalopathy 46.59 12.78 62 18506 33527 46633967
Hypotension 46.25 12.78 199 18369 232390 46435104
Airway peak pressure increased 43.61 12.78 12 18556 284 46667210
Respiratory acidosis 42.73 12.78 28 18540 6120 46661374
Blood gases abnormal 42.41 12.78 14 18554 624 46666870
Lung hyperinflation 41.09 12.78 16 18552 1153 46666341
Completed suicide 40.85 12.78 5 18563 145915 46521579
Febrile neutropenia 39.47 12.78 104 18464 94523 46572971
Status epilepticus 38.72 12.78 37 18531 13942 46653552
Respiratory failure 38.32 12.78 103 18465 94713 46572781
Neuromuscular blockade 38.05 12.78 11 18557 313 46667181
Left ventricular dysfunction 38.02 12.78 32 18536 10223 46657271
Neonatal respiratory distress syndrome 37.82 12.78 19 18549 2514 46664980
Joint swelling 37.26 12.78 10 18558 166063 46501431
Hypercapnia 36.95 12.78 23 18545 4603 46662891
Foetal growth restriction 36.38 12.78 26 18542 6541 46660953
Blood magnesium increased 34.63 12.78 19 18549 3008 46664486
Apgar score low 34.33 12.78 12 18556 637 46666857
PO2 decreased 33.76 12.78 15 18553 1507 46665987
HELLP syndrome 33.70 12.78 13 18555 913 46666581
Status asthmaticus 33.57 12.78 13 18555 923 46666571
Acute respiratory failure 33.27 12.78 49 18519 29089 46638405
Neuromuscular block prolonged 32.40 12.78 11 18557 535 46666959
Septic shock 32.04 12.78 71 18497 57822 46609672
Blood calcium decreased 31.65 12.78 35 18533 15638 46651856
Shock 29.79 12.78 40 18528 21805 46645689
Metabolic acidosis 29.13 12.78 54 18514 38726 46628768
Hypokalaemia 28.20 12.78 88 18480 87936 46579558
Craniotabes 27.32 12.78 4 18564 0 46667494
Cardiac arrest 26.80 12.78 88 18480 90311 46577183
Tachypnoea 25.51 12.78 30 18538 14321 46653173
Renal impairment 25.36 12.78 76 18492 74296 46593198
Acute respiratory distress syndrome 25.22 12.78 37 18531 21885 46645609
Infantile apnoea 25.09 12.78 10 18558 766 46666728
Alopecia 24.96 12.78 17 18551 162397 46505097
Maternal exposure during delivery 24.61 12.78 10 18558 806 46666688
Torsade de pointes 24.29 12.78 27 18541 12127 46655367
Electroencephalogram abnormal 23.45 12.78 16 18552 3738 46663756
Neonatal disorder 23.12 12.78 9 18559 648 46666846
Cyanosis 22.94 12.78 30 18538 15941 46651553
Endometritis 22.85 12.78 10 18558 969 46666525
Hyperkalaemia 22.43 12.78 57 18511 50652 46616842
Peripheral swelling 22.41 12.78 18 18550 158053 46509441
Treatment failure 22.04 12.78 5 18563 93082 46574412
Electrocardiogram QT prolonged 21.98 12.78 57 18511 51268 46616226
Fear 21.12 12.78 29 18539 16143 46651351
Colitis 20.88 12.78 46 18522 37301 46630193
Renal failure 20.86 12.78 95 18473 113499 46553995
Sinusitis 20.73 12.78 13 18555 129755 46537739
Multiple organ dysfunction syndrome 20.70 12.78 56 18512 51654 46615840
Drug intolerance 20.53 12.78 17 18551 147032 46520462
Delayed fontanelle closure 20.51 12.78 4 18564 18 46667476
Device related sepsis 20.51 12.78 14 18554 3273 46664221
Renal injury 20.47 12.78 22 18546 9519 46657975
Osmotic demyelination syndrome 20.34 12.78 8 18560 592 46666902
Sepsis 20.15 12.78 107 18461 135907 46531587
Neonatal infection 19.70 12.78 6 18562 205 46667289
Perforation 19.59 12.78 9 18559 978 46666516
Ventricular extrasystoles 19.45 12.78 23 18545 11040 46656454
Acidosis 19.26 12.78 23 18545 11151 46656343
Disseminated intravascular coagulation 18.93 12.78 30 18538 18975 46648519
Therapeutic product effect incomplete 18.90 12.78 4 18564 78149 46589345
Hypoventilation neonatal 18.41 12.78 3 18565 3 46667491
Maternal drugs affecting foetus 17.99 12.78 16 18552 5502 46661992
Clonus 17.80 12.78 14 18554 4066 46663428
Respiratory distress 17.49 12.78 39 18529 31877 46635617
Herpes zoster 17.42 12.78 3 18565 67869 46599625
Product compounding quality issue 17.37 12.78 5 18563 140 46667354
Acute kidney injury 17.26 12.78 156 18412 235699 46431795
Respiratory rate increased 17.24 12.78 22 18546 11411 46656083
Small for dates baby 17.00 12.78 13 18555 3624 46663870
Sensory level abnormal 16.70 12.78 5 18563 161 46667333
Therapeutic product effect decreased 16.67 12.78 6 18562 82595 46584899
Bronchitis 16.40 12.78 11 18557 105968 46561526
Cystitis-like symptom 16.34 12.78 3 18565 9 46667485
Urine output decreased 16.18 12.78 21 18547 11076 46656418
Macular degeneration 16.14 12.78 17 18551 7188 46660306
Colitis ischaemic 16.08 12.78 20 18548 10112 46657382
Immune effector cell-associated neurotoxicity syndrome 15.91 12.78 7 18561 687 46666807
Heparin-induced thrombocytopenia 15.06 12.78 13 18555 4296 46663198
Medication error 14.99 12.78 36 18532 30875 46636619
Diastolic hypotension 14.90 12.78 4 18564 86 46667408
Tetany 14.64 12.78 9 18559 1762 46665732
Headache 14.62 12.78 121 18447 478231 46189263
Tachycardia 14.49 12.78 78 18490 99544 46567950
Delayed recovery from anaesthesia 14.47 12.78 7 18561 854 46666640
Foetal growth abnormality 14.26 12.78 3 18565 21 46667473
Arthropathy 14.20 12.78 8 18560 84692 46582802
Influenza 14.17 12.78 9 18559 89261 46578233
Vascular resistance systemic decreased 14 12.78 4 18564 109 46667385
Stillbirth 13.98 12.78 15 18553 6476 46661018
Osteoarthritis 13.40 12.78 4 18564 62021 46605473
Apallic syndrome 13.37 12.78 6 18562 617 46666877
Eclampsia 13.32 12.78 5 18563 326 46667168
Systemic candida 13.30 12.78 10 18558 2717 46664777
Thrombocytopenia 13.26 12.78 91 18477 126490 46541004
Blood creatine phosphokinase increased 13.13 12.78 32 18536 27692 46639802
Cardiac output increased 13.07 12.78 4 18564 139 46667355
Nasopharyngitis 13.00 12.78 26 18542 153972 46513522
Weight increased 12.86 12.78 29 18539 164444 46503050
Musculoskeletal stiffness 12.86 12.78 12 18556 97981 46569513

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Premature baby 120.86 13.01 80 12696 16611 29923091
Cytokine release syndrome 72.83 13.01 48 12728 9885 29929817
Foetal exposure during pregnancy 61.18 13.01 77 12699 36794 29902908
Low birth weight baby 56.15 13.01 34 12742 6042 29933660
Tachycardia foetal 55.14 13.01 15 12761 316 29939386
Foetal distress syndrome 46.24 13.01 17 12759 974 29938728
Fear 42.59 13.01 36 12740 10789 29928913
Anhedonia 41.79 13.01 32 12744 8337 29931365
Febrile neutropenia 39.19 13.01 117 12659 106576 29833126
Sepsis 38.19 13.01 143 12633 146252 29793450
Apgar score low 36.97 13.01 14 12762 871 29938831
Injury 30.77 13.01 42 12734 21689 29918013
Immune effector cell-associated neurotoxicity syndrome 30.28 13.01 12 12764 844 29938858
Hypomagnesaemia 29.66 13.01 36 12740 16562 29923140
Hypermagnesaemia 28.50 13.01 8 12768 190 29939512
Caesarean section 27.93 13.01 15 12761 2122 29937580
Renal injury 26.99 13.01 29 12747 11700 29928002
Completed suicide 24.75 13.01 6 12770 99486 29840216
Respiratory failure 24.30 13.01 96 12680 100546 29839156
Hypoxia 24.09 13.01 59 12717 47795 29891907
Unevaluable event 23.80 13.01 46 12730 31739 29907963
Hypotension 23.46 13.01 156 12620 200409 29739293
Emotional distress 23.12 13.01 31 12745 15734 29923968
Maternal drugs affecting foetus 22.79 13.01 17 12759 4256 29935446
Multiple organ dysfunction syndrome 22.69 13.01 69 12707 63418 29876284
Device related infection 21.29 13.01 31 12745 16984 29922718
Blood potassium decreased 20.33 13.01 30 12746 16632 29923070
Drug abuse 20.31 13.01 5 12771 82067 29857635
Product contamination 19.19 13.01 8 12768 641 29939061
Mixed dementia 19.18 13.01 6 12770 209 29939493
Drug interaction 19.12 13.01 35 12741 199533 29740169
Bradycardia foetal 18.08 13.01 6 12770 253 29939449
Patent ductus arteriosus 17.78 13.01 13 12763 3156 29936546
Ureteric stenosis 17.10 13.01 9 12767 1222 29938480
Toxicity to various agents 17.03 13.01 31 12745 177152 29762550
Neonatal asphyxia 16.68 13.01 6 12770 323 29939379
Pantoea agglomerans infection 16.51 13.01 4 12772 52 29939650
Renal failure 16.08 13.01 102 12674 128864 29810838
Respiratory distress 15.90 13.01 40 12736 32932 29906770
Hypokalaemia 15.59 13.01 52 12724 50140 29889562
Acute respiratory failure 15.33 13.01 34 12742 25816 29913886
Foetal heart rate deceleration abnormality 15.14 13.01 6 12770 422 29939280
Transverse presentation 14.76 13.01 4 12772 83 29939619
Burkholderia test positive 14.73 13.01 6 12770 453 29939249
Foetal exposure timing unspecified 14.61 13.01 5 12771 232 29939470
Catheter site related reaction 13.92 13.01 5 12771 268 29939434
Electrocardiogram QT prolonged 13.79 13.01 40 12736 35795 29903907
Apnoea 13.57 13.01 15 12761 6243 29933459
Bacteraemia 13.50 13.01 24 12752 15536 29924166
Drug ineffective 13.26 13.01 88 12688 340299 29599403
Exposure during pregnancy 13.26 13.01 18 12758 9243 29930459
Neonatal respiratory distress syndrome 13.09 13.01 12 12764 4000 29935702
Incision site pain 13.04 13.01 9 12767 1995 29937707

Pharmacologic Action:

SourceCodeDescription
ATC A06AD04 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR CONSTIPATION
DRUGS FOR CONSTIPATION
Osmotically acting laxatives
ATC A12CC02 ALIMENTARY TRACT AND METABOLISM
MINERAL SUPPLEMENTS
OTHER MINERAL SUPPLEMENTS
Magnesium
ATC B05XA05 BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
I.V. SOLUTION ADDITIVES
Electrolyte solutions
ATC D11AX05 DERMATOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
OTHER DERMATOLOGICAL PREPARATIONS
Other dermatologicals
ATC V04CC02 VARIOUS
DIAGNOSTIC AGENTS
OTHER DIAGNOSTIC AGENTS
Tests for bile duct patency
MeSH PA D000700 Analgesics
MeSH PA D000777 Anesthetics
MeSH PA D000889 Anti-Arrhythmia Agents
MeSH PA D000927 Anticonvulsants
MeSH PA D002121 Calcium Channel Blockers
MeSH PA D000077264 Calcium-Regulating Hormones and Agents
MeSH PA D002317 Cardiovascular Agents
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D049990 Membrane Transport Modulators
MeSH PA D018373 Peripheral Nervous System Agents
MeSH PA D012102 Reproductive Control Agents
MeSH PA D018689 Sensory System Agents
MeSH PA D015149 Tocolytic Agents
CHEBI has role CHEBI:50503 laxatives
CHEBI has role CHEBI:75325 cathartics
CHEBI has role CHEBI:33287 fertiliser
CHEBI has role CHEBI:35554 cardiovascular drugs
CHEBI has role CHEBI:35623 antiepileptic
CHEBI has role CHEBI:38070 antiarrhythmic agent
CHEBI has role CHEBI:38215 calcium channel blockers
CHEBI has role CHEBI:38867 anaesthetic
CHEBI has role CHEBI:66993 anti-contraction drug

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Constipation indication 14760008 DOID:2089
Mild pre-eclampsia indication 41114007
Severe pre-eclampsia indication 46764007
Hypomagnesemia indication 190855004
Eclampsia in pregnancy indication 198992004
Incomplete passage of stool indication 249515001
Torsades de pointes off-label use 31722008
Atypical Ventricular Tachycardia off-label use
Hypocalcemia contraindication 5291005
Hyperkalemia contraindication 14140009
Complete atrioventricular block contraindication 27885002
Dehydration contraindication 34095006
Gastrointestinal ulcer contraindication 40845000
Congenital myotonia, autosomal dominant form contraindication 57938005
Acute nephropathy contraindication 58574008
Hypermagnesemia contraindication 66978005
Appendicitis contraindication 74400008 DOID:8337
Kidney disease contraindication 90708001 DOID:557
Gastrointestinal obstruction contraindication 126765001
Gastroparesis contraindication 235675006
Chronic diarrhea contraindication 236071009
Hyporeninemic hypoaldosteronism contraindication 236464008
Familial hyperkalemic periodic paralysis contraindication 304737009 DOID:14451
Severe dehydration contraindication 450316000

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
0.225GM;0.188GM;1.479GM SUTAB (COPACKAGED) BRAINTREE LABS N213135 Nov. 10, 2020 RX TABLET ORAL Nov. 10, 2023 NEW PRODUCT
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT SUPREP BOWEL PREP KIT BRAINTREE LABS N022372 Aug. 5, 2010 RX SOLUTION ORAL Aug. 5, 2027 FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER

Bioactivity Summary:

None

External reference:

IDSource
4019181 VUID
N0000147424 NUI
10034-99-8 SECONDARY_CAS_RN
4000969 VANDF
4017468 VANDF
4017680 VANDF
4019181 VANDF
C2961685 UMLSCUI
CHEBI:31795 CHEBI
CHEMBL3989857 ChEMBL_ID
CHEMBL2021423 ChEMBL_ID
D008278 MESH_DESCRIPTOR_UI
DB00653 DRUGBANK_ID
24843 PUBCHEM_CID
ML30MJ2U7I UNII
1053346 RXNORM
173828 MMSL
173829 MMSL
26390 MMSL
36335 MMSL
5017 MMSL
5259 MMSL
6287 MMSL
7114 MMSL
d00468 MMSL
000789 NDDF
001184 NDDF
003022 NDDF
006708 NDDF
37400007 SNOMEDCT_US
387202002 SNOMEDCT_US
725797001 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4204 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4205 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4206 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0264-4400 INJECTION, SOLUTION 10 mg INTRAVENOUS ANDA 26 sections
TIS-U-SOL HUMAN PRESCRIPTION DRUG LABEL 5 0338-0190 IRRIGANT 20 mg IRRIGATION NDA 5 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1708 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 20 sections
MAGNESIUM SULFATE IN DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-1709 INJECTION, SOLUTION 10 mg INTRAVENOUS ANDA 23 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1715 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1719 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 0363-0942 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 14 sections
Humco Epson Salt HUMAN OTC DRUG LABEL 1 0395-0807 POWDER, FOR SOLUTION 1000 mg ORAL OTC monograph not final 10 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0409-1754 INJECTION, SOLUTION 500 mg INTRAVENOUS ANDA 13 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0409-2168 INJECTION, SOLUTION 500 mg INTRAVENOUS ANDA 22 sections
Magnesium Sulfate in Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0409-6727 INJECTION, SOLUTION 10 mg INTRAVENOUS NDA 26 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0409-6729 INJECTION, SOLUTION 40 mg INTRAVENOUS NDA 13 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0409-6730 INJECTION, SOLUTION 80 mg INTRAVENOUS NDA 13 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 0869-0602 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 11 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 11673-200 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 16 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 11673-602 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 12 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 21130-602 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 12 sections
Epsom SaltsRelief HUMAN OTC DRUG LABEL 1 22431-124 GRANULE 100 g ORAL OTC monograph not final 8 sections
Relief Epsom Salt HUMAN OTC DRUG LABEL 1 22431-248 GRANULE 3.63 kg ORAL OTC monograph not final 8 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 25021-612 INJECTION, SOLUTION 40 mg INTRAVENOUS ANDA 21 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 30142-602 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 14 sections
Epsom Salts HUMAN OTC DRUG LABEL 1 30400-210 GRANULE 100 g ORAL OTC monograph not final 8 sections
Assured Epsom Salt HUMAN OTC DRUG LABEL 1 33992-3020 GRANULE 100 g ORAL OTC monograph not final 8 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 36800-602 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 13 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 37012-602 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 12 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 37205-602 CRYSTAL 1 g ORAL OTC monograph not final 12 sections
SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE HUMAN PRESCRIPTION DRUG LABEL 3 40032-700 SOLUTION 1.60 g ORAL ANDA 25 sections